tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CARM Stock Latest News

Carisma Therapeutics initiated with a Buy at BTIG
The FlyCarisma Therapeutics initiated with a Buy at BTIG
8d ago
CARM
Carisma Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
PremiumThe Fly
Carisma Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
17d ago
CARM
Carisma Therapeutics’ Compliance Hurdle: Navigating Anti-Kickback and Fraud Laws in the Pharmaceutical Landscape
PremiumCompany Announcements
Carisma Therapeutics’ Compliance Hurdle: Navigating Anti-Kickback and Fraud Laws in the Pharmaceutical Landscape
17d ago
CARM
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
18d ago
CARM
Carisma Therapeutics reports Q2 EPS (52c), consensus (55c)
PremiumThe Fly
Carisma Therapeutics reports Q2 EPS (52c), consensus (55c)
18d ago
CARM
Carisma Therapeutics nominates first lead candidate in Moderna collaboration
PremiumThe FlyCarisma Therapeutics nominates first lead candidate in Moderna collaboration
4M ago
CARM
MRNA
Carisma Therapeutics: FDA clears IND application for CT-0525
PremiumThe Fly
Carisma Therapeutics: FDA clears IND application for CT-0525
5M ago
CARM
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
5M ago
CARM
Carisma Therapeutics reports Q3 EPS (53c), consensus (57c)
PremiumThe Fly
Carisma Therapeutics reports Q3 EPS (53c), consensus (57c)
5M ago
CARM
Carisma Therapeutics to present efficacy results of Moderna collaboration
PremiumThe Fly
Carisma Therapeutics to present efficacy results of Moderna collaboration
6M ago
CARM
MRNA
Capital One starts Carisma Therapeutics at Overweight, sees 134% upside
PremiumThe Fly
Capital One starts Carisma Therapeutics at Overweight, sees 134% upside
7M ago
CARM
Carisma Therapeutics initiated with an Overweight at Capital One
PremiumThe Fly
Carisma Therapeutics initiated with an Overweight at Capital One
7M ago
CARM
Carisma Therapeutics to report latest data from Phase 1 trial of CT-0508
PremiumThe FlyCarisma Therapeutics to report latest data from Phase 1 trial of CT-0508
8M ago
CARM
Carisma Therapeutics price target raised to $11 from $10 at H.C. Wainwright
PremiumThe Fly
Carisma Therapeutics price target raised to $11 from $10 at H.C. Wainwright
8M ago
CARM
Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
PremiumPress Releases
Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
8M ago
CARM
Carisma Therapeutics reports Q2 EPS (49c), consensus (60c)
PremiumThe Fly
Carisma Therapeutics reports Q2 EPS (49c), consensus (60c)
8M ago
CARM
Carisma Therapeutics initiated with an Outperform at Evercore ISI
PremiumThe Fly
Carisma Therapeutics initiated with an Outperform at Evercore ISI
10M ago
CARM
Carisma announces first patient dosed in Phase I clinical trial of CT-0508
PremiumThe Fly
Carisma announces first patient dosed in Phase I clinical trial of CT-0508
10M ago
NVS
CARM
Carisma to be added to Russell 2000, Russell 3000, and Russell Microcap
PremiumThe Fly
Carisma to be added to Russell 2000, Russell 3000, and Russell Microcap
10M ago
CARM
Carisma Therapeutics Shines on New Cancer Treatment
PremiumMarket NewsCarisma Therapeutics Shines on New Cancer Treatment
11M ago
CARM
MRNA
Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
PremiumPress Releases
Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
11M ago
CARM
Carisma Therapeutics initiated with an Outperform at Baird
PremiumThe Fly
Carisma Therapeutics initiated with an Outperform at Baird
1y ago
CARM
MRNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >